Endocrine and Diabetes Biomarkers

A biomarker is defined as any substance, structure, or process that can be measured in the body or its products and influence or predict the incidence of outcome or disease. For the purpose of predicting type 1 diabetes, a biomarker should be present in a subset of the population, and this subset should have a bias in the proportion of people in whom type 1 diabetes develops. A biomarker should also present a quantifiable risk for the development of type 1 diabetes within a defined period or diagnose a “stage” in the progression to clinical or symptomatic type 1 diabetes. As described in this article, most of the biomarkers used for the prediction of type 1 diabetes are islet-specific supporting the concept that, before overt hyperglycemia, type 1 diabetes is predominantly a targeted disease rather than a systemic disease.

Atomic Biomarkers can be separated as "a trademark that is precisely measured and gaged as a pointer of typical natural methods, pathogenic methodology, or pharmacologic reactions to a pharmaceutical intercession.

Biomarkers have fundamental influence in driving clinical trials and treating patients. Progresses in sub-atomic diagnostics help medicinal experts make proficient, experimentally legitimate choices. All the more efficient disclosure and use of biomarkers in the development of ant diabetes medications will rely on upon quickening our comprehension of the pathogenesis of diabetes and particularly its macro vascular entanglements. Procedural upgrades from different fields, particularly tumor, are starting to demonstrate the way towards better models of diabetes pathogenesis and atomic biomarker revelation.

  • Prognostic marker
  • Diabetic nephropathy marker
  • Molecular marker for metabolic syndrome
  • Molecular Marker-Hypoglycemic response
  • Inflammatory markers: Type 2 diabetes
  • Pharmacotherapy in treatment of diabetes

 

    Related Conference of Endocrine and Diabetes Biomarkers

    May 30-31, 2019

    2nd Global Meeting on Diabetes and Endocrinology

    Istanbul, Turkey
    July 29-30, 2019

    21st Asia Pacific Diabetes Conference

    Sydney, Australia
    June 27-28, 2019

    18th Global Conference on Diabetes & Nursing Care

    Amsterdam, Netherlands
    July 05-06, 2019

    12th World Congress on Diabetes & Endocrinology

    Columbus, USA
    July 17-18, 2019

    28th European Diabetes Congress

    | Edinburgh, Scotland
    September 18-19, 2019

    12th International Conference on Diabetes & Metabolism

    San Francisco | California | USA
    September 16-17, 2017

    International Conference on Diabetes and Heart diseases

    Athens, Greece
    September 20-21, 2019

    15th World Congress on Endocrinology & Diabetes

    | Prague, Czech Republic
    September 20-21, 2019 |

    Euro Diabetes Congress & Expo

    Prague, Czech Republic
    October 14-15, 2019

    Global congress on Endocrinology and Gynecology

    Sydney, Australia
    October 23-24, 2019

    World conference on Diabetes and Heart Congress

    Valencia,Spain
    October 23-24, 2019

    Annual Summit on Metabolomics

    Amsterdam, Netherlands
    October 25-26, 2019

    29th World Diabetes & Heart Congress

    | Radisson Narita | Tokyo, Japan
    November 25-26, 2019

    Global Summit On Diabetes & Endocrinology

    Yokohama, Japan
    November 29-30, 2019

    World conference on Diabetes and Endocrine Complications

    Barcelona,Spain
    December 02-03, 2019

    14th European Diabetes and Endocrinology Congress

    | Barcelona, Spain
    December 04-05, 2019

    3rd Annual Congress on Diabetes and Its Complications

    Tokyo, Japan
    December 12-13, 2019

    Annual Congress on Diabetes and Endocrinology

    | Dubai, UAE

    Endocrine and Diabetes Biomarkers Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in